CD8A and neoplasm: Other in vivo studies reported recovery or increase in the levels of circulating or tumor-infiltrating CD4+ and CD8+ T cells and of NK cells, and a decreased number of tumor-infiltrating MDSCs after administration of CUR or a CUR-based cocktail [43,45,85].